Cargando…

Misonidazole reduces blood flow in two experimental murine tumours.

The effects of single doses of misonidazole (MISO) on blood flow and vascular volume in the SaFA and CaNT tumours and normal tissues of the mouse have been studied. MISO was administered in the dose range 250-1,000 mg kg-1 and blood flow measured at different times after MISO by the 86RbCl extractio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, J. C., Randhawa, V. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246764/ https://www.ncbi.nlm.nih.gov/pubmed/3166901

Ejemplares similares

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987)

Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
por: Siemann, D. W.
Publicado: (1982)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
por: Stewart, F. A., et al.
Publicado: (1982)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
por: Rojas, A., et al.
Publicado: (1983)

Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
por: Law, M. P., et al.
Publicado: (1981)

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
por: Twentyman, P. R.
Publicado: (1981)

Influence of misonidazole on the incidence of radiation-induced intestinal tumours in mice.
por: Rostom, A. Y., et al.
Publicado: (1978)

The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice.
por: MacManus, M. P., et al.
Publicado: (1989)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
por: Horsman, M. R., et al.
Publicado: (1984)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
por: Lee, F. Y., et al.
Publicado: (1985)

In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
por: Siemann, D. W., et al.
Publicado: (1984)

A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
por: Abratt, R. P.
Publicado: (1982)

Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
por: Pedersen, J. E., et al.
Publicado: (1979)

The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
por: McNally, N. J.
Publicado: (1982)

Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
por: Brown, J. M., et al.
Publicado: (1982)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
por: Murray, D., et al.
Publicado: (1983)

In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
por: Bremner, J. C., et al.
Publicado: (1991)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.
por: Clarke, C., et al.
Publicado: (1982)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Intra-hepatic-arterial infusion of misonidazole--an experimental study of regional radiosensitisation by intraarterial embolisation.
por: Wang, Y., et al.
Publicado: (1992)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

Effect of misonidazole on radiation injury to mouse spinal cord.
por: Travis, E. L., et al.
Publicado: (1982)

Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
por: Moore, J. L., et al.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_j4upfbnsoeudr0ta4m0c1olucg